UnitedHealth Selected to Continue Serving Medicaid Members in Rhode Island-March 2024-www.financetom.com

UnitedHealth Selected to Continue Serving Medicaid Members in Rhode Island

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

UnitedHealth Selected to Continue Serving Medicaid Members in Rhode Island

Jul 17, 2024 2:55 PM

05:31 PM EDT, 07/17/2024 (MT Newswires) -- UnitedHealthcare, part of UnitedHealth Group ( UNH ) , said late Wednesday that the State of Rhode Island selected its Community Plan of Rhode Island to continue serving Medicaid members through the Medicaid Managed Care Services program.

Rhode Island citizens eligible for Medicaid will have access to UnitedHealthcare services and benefits through 2030.

The company did not disclose the financial details of the deal.

Price: 572.64, Change: -0.64, Percent Change: -0.11

Previous page： Canada's 2026 Economic Outlook Is "Cloudy" With A Chance of Tariffs, Says TD Next page： FDA approves BioCryst's oral pellet formulation of rare disease drug for young children

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Canada's 2026 Economic Outlook Is "Cloudy" With A Chance of Tariffs, Says TD

Mar 10, 2026

07:16 AM EST, 12/12/2025 (MT Newswires) -- Canada's outlook has a cloud hanging over its head, with the future of the United States trading relationship still undetermined, said TD. U.S. tariffs already in place are having clear impacts on Canada's economy, most obvious in the three straight quarters of businesses cutting back on investments, wrote the bank in its Canadian...

FDA approves BioCryst's oral pellet formulation of rare disease drug for young children

Mar 10, 2026

Dec 12 (Reuters) - The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' ( BCRX ) drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company said on Friday. The drug, Orladeyo, was already approved as a once-daily capsule for patients aged 12 and older in December 2020. With...

GXO Logistics Names Bart Beeks COO

Mar 10, 2026

07:16 AM EST, 12/12/2025 (MT Newswires) -- GXO Logistics ( GXO ) said Friday it has appointed Bart Beeks as its chief operating officer, effective Jan. 2. Beeks was previously Ceva Logistics' COO, GXO Logistics ( GXO ) said. ...

Telus to Buy Back $1.9 Billion of Notes

Mar 10, 2026

07:17 AM EST, 12/12/2025 (MT Newswires) -- Telus ( TU ) said Friday that it has increased its Dec. 4 offer to buy back seven series of notes, from the original $500 million, to $1.9 billion. The upsizing covers all the notes that were validly tendered by the Dec. 11 expiry date. The company earlier this week closed the concurrent...